查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573251

慢性病管理市场：按疾病类型、产品类型、最终用户、护理类型、交付模式 - 2025-2030 年全球预测

Chronic Disease Management Market by Disease Type (Cancer, Cardiovascular Diseases, Chronic Kidney Diseases), Product Type (Devices, Drugs, Services), End User, Care Type, Delivery Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年慢性病管理市场价值为93.3亿美元，预计2024年将达到101.2亿美元，复合年增长率为7.10%，到2030年将达到150.9亿美元。

慢性病管理 (CDM) 包括旨在管理和改善患有糖尿病、心血管疾病和气喘等长期非传染性疾病的患者的健康状况的全面、持续的护理和策略。由于人口老化、久坐的生活方式和不健康的饮食，慢性病在全球普遍流行，因此需要清洁发展机制。 CDM 的应用多种多样，包括远端医疗服务、病患教育、生活方式指导和药物管理，以确保有效的治疗依从性、减少住院治疗并提高生活品质。主要的最终用途部门包括医院、诊所、以患者为中心的组织和居家医疗，这些部门越来越多地采用 CDM 解决方案来提高护理效率。

主要市场统计
基准年[2023] 93.3亿美元
预测年份 [2024] 101.2亿美元
预测年份 [2030] 150.9亿美元
复合年增长率（%） 7.10%

影响该市场成长的关键因素包括健康监测设备的技术进步、远距远端医疗的日益普及以及将人工智慧 (AI) 整合到患者治疗计划中进行预测分析。提供远端监控和资料分析的可穿戴技术和行动医疗应用程式中存在的最新机会将极大地提高患者的参与度和对处方治疗方法的依从性。公司应该利用这些机会，推动以患者为中心的平台创新，整合人工智慧和物联网，实现即时健康追踪和个人化护理。

然而，挑战依然存在，包括资料隐私问题、医疗保健 IT 系统之间的互通性有限以及缺乏熟悉新兴医疗技术的熟练专业人员。经济差异影响清洁发展机制解决方案的取得并阻碍市场渗透，特别是在低收入地区。公司必须专注于建立安全、可互通的系统，优先考虑患者资料的安全性，同时倡导扩大服务不足市场准入的政策。

为了促进成长和创新，公司可以探索人工智慧驱动的预测分析、用于安全资料共用的区块链以及开发低成本、扩充性的数位健康平台等途径。 CDM市场是一个充满活力、以成长为导向的市场，以基于价值的护理模式为中心，旨在提高慢性病管理的整体效率和有效性。

市场动态：快速发展的慢性病管理市场的关键市场洞察

供需的动态交互作用正在改变慢性病管理市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球慢性病流行增加了对有效管理解决方案的需求
    • 医疗保健技术的进步提高了监测和管理慢性病的能力
    • 提高医疗保健提供者和患者对慢性病管理重要性的认识
    • 透过专注于慢性病管理的创新医疗服务模式改善患者治疗结果和体验
  • 市场限制因素
    • 先进治疗、技术和长期照护相关的高成本
    • 对资料外洩、未授权存取和敏感病患资讯遗失的担忧
  • 市场机会
    • 扩展行动医疗平台以解决服务不足社区的慢性病管理问题
    • 将人工智慧融入慢性病管理，提供个人化治疗方案
    • 开发远端监控解决方案以减少慢性疾病患者的再入院率
  • 市场挑战
    • 由于各个医疗保健提供者、专家和看护者之间缺乏协调，导致护理和沟通不一致
    • 难以确保患者遵守规定的治疗计划

波特五力：驾驭慢性病管理市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解慢性病管理市场的外部影响

外部宏观环境因素对慢性病管理市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解慢性病管理市场的竞争格局

慢性病管理市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 慢性病管理市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估慢性病管理市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了慢性病管理市场的成功之路

慢性病管理市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、核准核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病的盛行率不断增加，增加了对有效管理解决方案的需求。
      • 医疗保健技术的进步增强了监测和管理慢性病的能力
      • 提高医疗专业人员和患者对慢性病管理重要性的认识
      • 专注于改善病患治疗结果和体验的创新医疗服务模式
    • 抑制因素
      • 先进治疗、技术和长期照护相关的高成本
      • 对资料外洩、未授权存取和敏感病患资讯遗失的担忧
    • 机会
      • 扩展行动医疗平台以解决服务不足社区的慢性病管理问题
      • 将人工智慧融入慢性病管理，实现个人化治疗计划
      • 开发远端监控解决方案以减少慢性疾病患者的再入院率
    • 任务
      • 不同医疗保健提供者、专家和看护者之间缺乏协调导致护理不一致和沟通差距
      • 难以确保患者遵守规定的治疗计划
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章慢性病管理市场：依疾病类型

  • 癌症
  • 心血管疾病
  • 慢性肾臟病
  • 慢性呼吸道疾病
  • 糖尿病

第七章慢性病管理市场：依产品类型

  • 装置
    • 诊断设备
    • 监控装置
    • 治疗设备
  • 药物
    • 止痛药
    • 抗高血压药
    • 支气管扩张剂
    • 胰岛素
  • 服务
    • 家庭保健
    • 远端医疗

第八章慢性病管理市场：依最终使用者分类

  • 诊所
  • 家庭护理设置
  • 医院
  • 长期照护中心

第九章按护理类型分類的慢性病管理市场

  • 专业护理
  • 自我治疗

第十章以交付方式分類的慢性病管理市场

  • 云端基础
  • 本地

第十一章美洲慢性病管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太慢性病管理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲慢性病管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-535C62918B2F

The Chronic Disease Management Market was valued at USD 9.33 billion in 2023, expected to reach USD 10.12 billion in 2024, and is projected to grow at a CAGR of 7.10%, to USD 15.09 billion by 2030.

Chronic Disease Management (CDM) involves comprehensive, continuous care and strategies designed to manage and improve patients' well-being suffering from long-lasting, non-communicable ailments such as diabetes, cardiovascular disease, and asthma. The necessity of CDM arises from the growing global prevalence of chronic diseases fueled by aging populations, sedentary lifestyles, and unhealthy diets. Its applications span telehealth services, patient education, lifestyle coaching, and medication management to ensure effective treatment adherence, reduce hospitalizations, and improve life quality. End-use sectors primarily include hospitals, clinics, patient-centric organizations, and home healthcare, increasingly adopting CDM solutions to enhance care efficiency.

KEY MARKET STATISTICS
Base Year [2023] USD 9.33 billion
Estimated Year [2024] USD 10.12 billion
Forecast Year [2030] USD 15.09 billion
CAGR (%) 7.10%

Key factors influencing this market's growth include technological advancements in health monitoring devices, the rising adoption of telemedicine, and the integration of Artificial Intelligence (AI) for predictive analytics in patient treatment plans. Latest opportunities present in wearable technology and mobile health apps, which offer remote monitoring and data analytics, significantly improve patient engagement and adherence to prescribed therapies. Businesses should leverage these opportunities by fostering innovations in patient-centric platforms that integrate AI and IoT for real-time health tracking and personalized care.

However, challenges persist in data privacy concerns, limited interoperability between healthcare IT systems, and a lack of skilled professionals adept in emerging health technologies. Economic disparities impact access to CDM solutions, particularly in low-income regions, hindering market penetration. Companies must focus on building secure, interoperable systems that prioritize patient data security while advocating for policies that expand access to underserved markets.

To spur growth and innovation, businesses can explore avenues in AI-driven predictive analytics, blockchain for secure data sharing, and the development of low-cost, scalable digital health platforms. The CDM market represents a dynamic, growth-oriented landscape pivoting towards value-based care models, aiming to enhance the overall efficiency and efficacy of chronic disease management.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Disease Management Market

The Chronic Disease Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
    • Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
    • Growing awareness among healthcare providers and patients about the importance of chronic disease management
    • Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
  • Market Restraints
    • High cost associated with advanced treatments, technologies, and long-term care
    • Concerns over data breaches, unauthorized access, and loss of sensitive patient information
  • Market Opportunities
    • Expansion of mobile health platforms addressing chronic disease management in underserved communities
    • Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
    • Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
  • Market Challenges
    • Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
    • Difficulties in ensuring patients adherence to their prescribed treatment plans

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Disease Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Disease Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Disease Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Disease Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Disease Management Market

A detailed market share analysis in the Chronic Disease Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Disease Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Disease Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Disease Management Market

A strategic analysis of the Chronic Disease Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Disease Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, Glooko, Inc., Health Catalyst Inc., Hinge Health, Inc., Lark Technologies, Inc., Livongo Health, Inc., Medtronic plc, Merck & Co., Inc., MySugr GmbH, Novo Nordisk A/S, Omada Health, Inc., Propeller Health, Roche Holding AG, Sanofi S.A., Virta Health Corp., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Chronic Disease Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Cancer, Cardiovascular Diseases, Chronic Kidney Diseases, Chronic Respiratory Diseases, and Diabetes.
  • Based on Product Type, market is studied across Devices, Drugs, and Services. The Devices is further studied across Diagnostic Devices, Monitoring Devices, and Therapeutic Devices. The Drugs is further studied across Analgesics, Antihypertensive, Bronchodilators, and Insulin. The Services is further studied across Home Healthcare and Telemedicine.
  • Based on End User, market is studied across Clinics, Homecare Settings, Hospitals, and Long-term Care Centers.
  • Based on Care Type, market is studied across Professional Care and Self-care.
  • Based on Delivery Mode, market is studied across Cloud-based and On-premise.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases globally driving higher demand for effective management solutions
      • 5.1.1.2. Advancements in healthcare technology enhancing chronic disease monitoring and management capabilities
      • 5.1.1.3. Growing awareness among healthcare providers and patients about the importance of chronic disease management
      • 5.1.1.4. Innovative healthcare delivery models focused on chronic disease management improving patient outcomes and experiences
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with advanced treatments, technologies, and long-term care
      • 5.1.2.2. Concerns over data breaches, unauthorized access, and loss of sensitive patient information
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of mobile health platforms addressing chronic disease management in underserved communities
      • 5.1.3.2. Integration of artificial intelligence in chronic disease management allowing for personalized treatment plans
      • 5.1.3.3. Development of remote monitoring solutions for chronic disease patients to reduce hospital readmissions
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of coordination among various healthcare providers, specialists, and caregivers leading to inconsistent care and communication gaps
      • 5.1.4.2. Difficulties in ensuring patients adherence to their prescribed treatment plans
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chronic Disease Management Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Cardiovascular Diseases
  • 6.4. Chronic Kidney Diseases
  • 6.5. Chronic Respiratory Diseases
  • 6.6. Diabetes

7. Chronic Disease Management Market, by Product Type

  • 7.1. Introduction
  • 7.2. Devices
    • 7.2.1. Diagnostic Devices
    • 7.2.2. Monitoring Devices
    • 7.2.3. Therapeutic Devices
  • 7.3. Drugs
    • 7.3.1. Analgesics
    • 7.3.2. Antihypertensive
    • 7.3.3. Bronchodilators
    • 7.3.4. Insulin
  • 7.4. Services
    • 7.4.1. Home Healthcare
    • 7.4.2. Telemedicine

8. Chronic Disease Management Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Homecare Settings
  • 8.4. Hospitals
  • 8.5. Long-term Care Centers

9. Chronic Disease Management Market, by Care Type

  • 9.1. Introduction
  • 9.2. Professional Care
  • 9.3. Self-care

10. Chronic Disease Management Market, by Delivery Mode

  • 10.1. Introduction
  • 10.2. Cloud-based
  • 10.3. On-premise

11. Americas Chronic Disease Management Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Chronic Disease Management Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Chronic Disease Management Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AstraZeneca plc
  • 3. Boehringer Ingelheim GmbH
  • 4. DexCom, Inc.
  • 5. Eli Lilly and Company
  • 6. Glooko, Inc.
  • 7. Health Catalyst Inc.
  • 8. Hinge Health, Inc.
  • 9. Lark Technologies, Inc.
  • 10. Livongo Health, Inc.
  • 11. Medtronic plc
  • 12. Merck & Co., Inc.
  • 13. MySugr GmbH
  • 14. Novo Nordisk A/S
  • 15. Omada Health, Inc.
  • 16. Propeller Health
  • 17. Roche Holding AG
  • 18. Sanofi S.A.
  • 19. Virta Health Corp.
  • 20. Welldoc, Inc.

LIST OF FIGURES

  • FIGURE 1. CHRONIC DISEASE MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CHRONIC DISEASE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHRONIC DISEASE MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHRONIC DISEASE MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CHRONIC RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANTIHYPERTENSIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PROFESSIONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SELF-CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)

TABLE 333.